OxyContin Maker Purdue Pharma Files for Bankruptcy to Settle Thousands of Lawsui

OxyContin Maker Purdue Pharma Files for Bankruptcy to Settle Thousands of Lawsuits

OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation’s deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity.

 

Whether the company can pull it off remains to be seen, especially with about half the states opposed to the deal.

 

The pharmaceutical giant filed for bankruptcy late Sunday, step one in a plan it says would provide $10 billion to $12 billion to help reimburse state and local governments and clean up the damage done by powerful prescription painkillers and illegal opioids like heroin and fentanyl, which together have been blamed for more than 400,000 deaths in the U.S. in the past two decades.

 

The plan calls for turning Purdue into a “public benefit trust” that would continue selling opioids but hand its profits over to those who have sued the company. The Sackler family would give up ownership of Purdue and contribute at least $3 billion toward the settlement.

 

It will be up to a federal bankruptcy judge to decide whether to approve or reject the settlement or seek modifications.

 

Two dozen states plus key lawyers who represent many of the 2,000-plus local governments suing the Stamford, Connecticut-based company have signed on to the plan.